DeepMed Research

University of Virginia

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1819-01-01

Employees: 10K

Market Cap: -

Website: http://www.virginia.edu

Clinical Trials

Echocardiography as Risk-Assessment for Major Adverse Cardiac Events in Major Vascular Surgery Patients

Completed

Conditions: Right-Sided Heart Failure
Left-Sided Heart Failure
Heart Valve Diseases

First Posted Date: 2021-04-08

Last Posted Date: 2024-06-14

Lead Sponsor: University of Virginia

Target Recruit Count: 813

Registration Number: NCT04836702

ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis

Phase 1

Terminated

Conditions: Adhesive Capsulitis
Frozen Shoulder
Adhesive Capsulitis of Shoulder

Interventions: Drug: triamcinolone acetonide extended-release injectable suspension

First Posted Date: 2021-04-05

Last Posted Date: 2025-05-13

Lead Sponsor: University of Virginia

Target Recruit Count: 39

Registration Number: NCT04831255

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Alpha-gal Pork Challenge

Not Applicable

Conditions: Allergy;Food

First Posted Date: 2021-04-02

Last Posted Date: 2021-04-02

Lead Sponsor: University of Virginia

Target Recruit Count: 54

Registration Number: NCT04828317

Adaptive Biobehavioral Control (ABC) of Automated Insulin Delivery

Not Applicable

Completed

Conditions: Type 1 Diabetes Mellitus

Interventions: Device: Web Simulation Tool (WST)
Device: Auto Titration Module (ATM)
Device: Behavioral Adaptation Module (BAM)
Device: Automated Insulin Delivery (AID) System

First Posted Date: 2021-03-05

Last Posted Date: 2024-11-07

Lead Sponsor: University of Virginia

Target Recruit Count: 31

Registration Number: NCT04784637

Locations: 🇺🇸
University of Virginia Center for Diabetes Technology, Charlottesville, Virginia, United States

Effectiveness of Exparel TAP Block in Breast Free Flap Reconstruction

Phase 4

Completed

Conditions: Postoperative Pain
Breast Reconstruction

Interventions: Drug: Liposomal bupivacaine TAP block
Drug: Bupivacain

First Posted Date: 2021-03-02

Last Posted Date: 2024-08-23

Lead Sponsor: University of Virginia

Target Recruit Count: 117

Registration Number: NCT04777591

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States
🇺🇸
University of Virginia Medical Center, Charlottesville, Virginia, United States

Impaired Glucose Tolerance and Cognition in MS

Terminated

Conditions: Multiple Sclerosis

First Posted Date: 2021-02-10

Last Posted Date: 2021-02-10

Lead Sponsor: University of Virginia

Target Recruit Count: 7

Registration Number: NCT04748302

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL

Phase 2

Recruiting

Conditions: PTCL

Interventions: Drug: Azacytidine
Drug: Romidepsin
Drug: Belinostat
Drug: Pralatrexate
Drug: Gemcitabine

First Posted Date: 2021-02-10

Last Posted Date: 2024-08-07

Lead Sponsor: University of Virginia

Target Recruit Count: 50

Registration Number: NCT04747236

Locations: 🇺🇸
Duke University, Durham, North Carolina, United States
🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇺🇸
University of Virginia, Charlottesville, Virginia, United States

and more 2 locations

Efficacy of Contrast Enhanced Voiding Urosonography for Urodynamic Studies

Conditions: Neurologic Dysfunction
Neurogenic Bladder
Myelomeningocele
Tethered Cord Syndrome
Bladder, Neurogenic
Urologic Diseases

Interventions: Drug: Contrast Enhanced Voiding Urosonography with Urodynamic Testing
Diagnostic Test: Urodynamic Testing

First Posted Date: 2021-02-04

Last Posted Date: 2021-04-28

Lead Sponsor: University of Virginia

Target Recruit Count: 105

Registration Number: NCT04738539

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Reduction in Number of Botox Injections for Urgency Urinary Incontinence

Not Applicable

Recruiting

Conditions: Urgency Urinary Incontinence

Interventions: Procedure: Experimental Arm (5 Botox injections)
Procedure: Standard of care (15 Botox injections)

First Posted Date: 2021-02-01

Last Posted Date: 2025-01-28

Lead Sponsor: University of Virginia

Target Recruit Count: 56

Registration Number: NCT04731961

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

Effect of Postprandial Hyperglycemia on Vasculature in Type 1 Diabetes and Healthy Adults

Completed

Conditions: Hyperglycemia, Postprandial
Type 1 Diabetes

Interventions: Dietary Supplement: Mixed Meal

First Posted Date: 2021-01-29

Last Posted Date: 2025-03-30

Lead Sponsor: University of Virginia

Target Recruit Count: 36

Registration Number: NCT04730882

Locations: 🇺🇸
University of Virginia, Charlottesville, Virginia, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy